A functional polymorphism in MMP-9 is associated with childhood atopic asthma.

Area of Science:

• Genetics
• Immunology
• Respiratory Medicine

Background:

• Matrix metalloproteinase-9 (MMP-9) plays a role in inflammation and tissue remodeling, processes implicated in asthma.
• The specific genetic influences of MMP-9 polymorphisms on asthma development remain largely uncharacterized.

Purpose of the Study:

• To investigate the association between MMP-9 gene polymorphisms and the risk of childhood atopic asthma.
• To explore the functional impact of identified polymorphisms on MMP-9 gene expression.

Main Methods:

• An association study was conducted involving 290 children with asthma and 638 controls.
• Seventeen MMP-9 polymorphisms were identified and analyzed, including haplotype analysis.
• MMP-9 expression in human bronchial epithelial cells was examined, and the effect of a promoter single nucleotide polymorphism (SNP) on transcriptional activity was assessed.

Main Results:

• Two specific MMP-9 polymorphisms, 2127G>T and 5546G>A (R668Q), showed a significant association with increased risk of childhood atopic asthma (p = 0.0032 and p = 0.0016, respectively).
• Haplotype analysis also revealed a significant positive association (p = 0.0053).
• The promoter SNP -1590C>T, in linkage disequilibrium with 2127G>T, was found to enhance MMP-9 transcriptional levels, and MMP-9 mRNA expression was upregulated by dsRNA in bronchial epithelial cells.

Conclusions:

• Functional genetic polymorphisms in the MMP-9 gene are associated with the risk of developing childhood atopic asthma.
• These findings suggest that MMP-9 genetic variations may contribute to asthma pathogenesis.